A distinctive expression profile of PDLIM1 which is critically involved in NF-κB-mediated inflammation has been observed in the blood of patients with several chronic diseases including cardiovascular disease, hypertension, dyslipidemia and T2DM43. This evidence concerns the gene NFKB1 and cardiovascular disorder.